Since the invention of the first biosensors 70 years ago, they have turned into valuable and versatile tools for various applications, ranging from disease diagnosis to environmental monitoring. Traditionally, antibodies have been employed as the capture probes in most biosensors, owing to their innate ability to bind their target with high affinity and specificity, and are still considered as the gold standard. Yet, the resulting immunosensors often suffer from considerable limitations, which are mainly ascribed to the antibody size, conjugation chemistry, stability, and costs. Over the past decade, aptamers have emerged as promising alternative capture probes presenting some advantages over existing constraints of immunosensors, as well as new biosensing concepts. Herein, we review the employment of antibodies and aptamers as capture probes in biosensing platforms, addressing the main aspects of biosensor design and mechanism. We also aim to compare both capture probe classes from theoretical and experimental perspectives. Yet, we highlight that such comparisons are not straightforward, and these two families of capture probes should not be necessarily perceived as competing but rather as complementary. We, thus, elaborate on their combined use in hybrid biosensing schemes benefiting from the advantages of each biorecognition element.
There
is a demonstrated and paramount need for rapid, reliable infectious
disease diagnostics, particularly those for invasive fungal infections.
Current clinical determinations for an appropriate antifungal therapy
can take up to 3 days using current antifungal susceptibility testing
methods, a time-to-readout that can prove detrimental for immunocompromised
patients and promote the spread of antifungal resistant pathogens.
Herein, we demonstrate the application of intensity-based reflectometric
interference spectroscopic measurements (termed iPRISM) on microstructured
silicon sensors for use as a rapid, phenotypic antifungal susceptibility
test. This diagnostic platform optically tracks morphological changes
of fungi corresponding to conidia growth and hyphal colonization at
a solid–liquid interface in real time. Using
Aspergillus
niger
as a model fungal pathogen, we can determine the minimal
inhibitory concentration of clinically relevant antifungals within
12 h. This assay allows for expedited detection of fungal growth and
provides a label-free alternative to broth microdilution and agar
diffusion methods, with the potential to be used for point-of-care
diagnostics.
Since its invention in the 1980s, 3D printing has evolved into a versatile technique for the additive manufacturing of diverse objects and tools, using various materials. The relative flexibility, straightforwardness, and ability to enable rapid prototyping are tremendous advantages offered by this technique compared to conventional methods for miniaturized and microfluidic systems fabrication (such as soft lithography). The development of 3D printers exhibiting high printer resolution has enabled the fabrication of accurate miniaturized and microfluidic systems-which have, in turn, substantially reduced both device sizes and required sample volumes. Moreover, the continuing development of translucent, heat resistant, and biocompatible materials will make 3D printing more and more useful for applications in biotechnology in the coming years. Today, a wide variety of 3D-printed objects in biotechnology-ranging from miniaturized cultivation chambers to microfluidic lab-on-a-chip devices for diagnosticsare already being deployed in labs across the world. This review explains the 3D printing technologies that are currently used to fabricate such miniaturized microfluidic devices, and also seeks to offer some insight into recent developments demonstrating the use of these tools for biotechnological applications such as cell culture, separation techniques, and biosensors.
Modern 3D printers enable not only rapid prototyping, but also high-precision printing—microfluidic devices with channel diameters of just a few micrometres can now be readily assembled using this technology. Such...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.